Terry F. Plasse

Dr. Terry F. Plasse is the current Medical Director at RedHill Biopharma. Terry has over four decades of experience in the medical field, specializing in oncology and clinical research.

Dr. Plasse started their career in 1973 as a Resident at Beth Israel Medical Center. Terry then completed a fellowship in Neoplastic Diseases at Mount Sinai Medical Center from 1978-1981. In 1993, they became the Director of Clinical Research-Oncology at Rhone-Poulenc Rorer and held this position until 1994. Afterwards, they spent six years as a Consultant at their own company, Plasse Associates, before joining Cytokine PharmaSciences as Vice President of Research and Development from 2000-2004.

In their current role at RedHill Biopharma, Dr. Plasse is responsible for leading the company's clinical development programs and providing oversight of all medical and scientific activities. Under their guidance, the company has achieved several milestones, including the successful completion of multiple Phase III clinical trials.

Terry F. Plasse has a MD from Washington University School of Medicine in St. Louis and an AB in Chemistry from Brandeis University.

Terry F. Plasse reports to Dror Ben-Asher, CEO. They work with Danielle Abramson - VP, Intellectual Property & Research, Reza Fathi - SVP R&D, and Shani Maurice - VP Business Development & Communications.